Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
16 Cards in this Set
- Front
- Back
|
docusate sodium (Colace)
Class: Laxitives Dosage:12y-Adult 100-240 mg/day Route: PO MOA:Promotes incorp of water into stool, resulting in softer fecal mass. May also promote electrolyte & water secretion into colon. Therapeutic Effect: softening & passage of stool. Onset: 24-48 hr (up to 3-5 days) Peak: Unknown Duration: Unknown |
Major S/E: EENT-throat irritation. GI-mild cramps. Derm-rashes.
Nursing: Assess for abd distention, bowel snds & bowel fx. Assess color, consistency, & amt of stool produced. PO-admin with full glass of water or juice. May be admin on empty stomach for rapid results. Do not admin w/in 2 hr of other lax, esp mineral oil. May cause incr absorption. |
|
|
polyethylene glycol (MiraLax)
Class: Therapeutic-laxitives, Pharmacologic-osmotics Dosage:17 g (heaping T) in 8 oz of water; may be used for up to 2 wk. Route: PO MOA:Acts as an osmotic agent, drawing water into the lumen of the GI tract. Therapeutic: Evacuation of the GI tract w/o water or electrolyte imbalance. Onset: Unk Peak: 2-4 days Duration: Unk |
Major S/E: GI-Abd bloatinting, cramping, flatulence, nausea
Nursing: Assess pt for abd distention, presence of bowel sounds & usual pattern of bowel fx. Assess color, consistency & amt of stool produced. Dissolve powder in 8 oz water prior to administration. |
|
|
ferrous gluconate
Class: Therapeutic-antianemics Pharmacologic-iron supplements Dosage:Adults (deficiency) 120-240 mg/day (2-3 mg/kg/day)in 2-4 divided doses (prophylaxis) 60-100 mg/day MOA: An essential mineral found in Hg, myoglobin & many enzymes. Perenteral irion enters bloodstream & organs of reticuloendothelial system(liver, spleen, bone marrow) where iron is separated out & becomes part of iron stores. Therapeutic: prev/trtment of iron deficiency. |
Onset: 4 days
Peak: 7-10 days Duration: 2-4 mos. Major S/E: GI-nausea, constipation, dark stools, diarrhea, epigastric pain. Nursing: Assess nutritional status & diet hx to det poss cause of anemia & need for pt teaching. Assess bowel fx for constipation or diarrhea. Notify physician if occurs Assess for s/s of anaphylaxis (rash, pruritus, laryngeal edema, wheezing). Notify ph Route: PO MOA:Promotes incorp of water into stool, resulting in softer fecal mass. May also promote electrolyte & water secretion into colon. Therapeutic Effect: softening & ys immediately if occur. Keep epi & resusc. equip close by. |
|
|
enoxaparin (Lovenox)
Low Molecular Weight Heparin Class: Therapeutic-anticoaglant Pharmacologic-antithrombotic Dosage: 40 mg/day Route: Subcutaneous MOA: Potentiates the inhibitory effect of antithrombin on factor Xa and thrombin. Therapeutic: Prevention of thrombus formation. Onset: Unk Peak: Unk Duration: 12 hr. |
Major S/E:CNS-dizziness, h/a, insomnia. CV-edema. GI-constipation, nausea, reversible incr in liver enzymes, vomiting. GU-urniary retention. Derm-ecchymoses, pruritus, rash, urticaria. Hemat-bleeding, anemia, thrombocytopenia. Local- erythema @ inj site, hematoma, irritation, pain. Misc-fever.
Nursing:Assess for signs of bleeding & hemorrhage; bleeding from surg site. Notify phys if occurs. Assess for evid of addtl or incr thrombosis. Monitor neuro freq for impriarment. Monitor for hypersens rxns Do not expel air bubble from syringe before injection. Inject into L or R antero or posterolateral abd wall only |
|
|
insulin-rapid acting (Novolog)
Class: Therapeutic-antidiabetics, hormones Pharmacologic-pancreatics Dosage: Depends on blood glucose, response & other factors. Adults 0.5-1 unit/kg/day. Route: Subcutaneous MOA: Lower blood glucose by stimulating glucose uptake in skeletal muscle & fat, inhibiting hepatic glucose prod. Therapeutic: Control of blood glucose in diabetic pts. |
Onset: 15 min Peak: 1-3 hr
Duration: 3-5 hr Major S/E: Derm-urticaria. Endo-hypoglycemia, rebound hyperglycemia. Local-lipodystrophy, itching, swelling redness. Mis-allergic rxns, incl anaphylaxis. Nursing: Assess pt for s/s of hypoglycemia (anxiety, restless, mood chg, tingling in hands feet, lips, tongue, chills, cold sweats, confusion, cool, pale skin, diff conc, drowsy, exc hunger, h/a, nausea, rapid pulse, shaky) & hyperglycemia (confusion, drowsy, flushed, dry skin, fruity breath, rapid deep breathing, freq urination. |
|
|
docusate sodium (Colace)
Class: Laxitives Dosage:12y-Adult 100-240 mg/day Route: PO MOA:Promotes incorp of water into stool, resulting in softer fecal mass. May also promote electrolyte & water secretion into colon. Therapeutic Effect: softening & passage of stool. Onset: 24-48 hr (up to 3-5 days) Peak: Unknown Duration: Unknown |
Major S/E: EENT-throat irritation. GI-mild cramps. Derm-rashes.
Nursing: Assess for abd distention, bowel snds & bowel fx. Assess color, consistency, & amt of stool produced. PO-admin with full glass of water or juice. May be admin on empty stomach for rapid results. Do not admin w/in 2 hr of other lax, esp mineral oil. May cause incr absorption. |
|
|
mupirocin (Bactroban Nasal)
Class: Therapeutic-anti-infective Dosage: Apply 3-5 times/day for 5-14 days Route: Topical MOA: Inhibits bacterial protein synthesis Therapeutic: Inhibition of bact growth & reproduction. Onset: Unk Peak: Unk Duration: 12 hr. |
Major S/E: CNS-h/a. EENT-cough, itching, pharyngitis, rhinitis, upper resp tract congestion. GI-nausea, altered taste. Derm-burning, itching, pain, stinging.
Nursing: Assess lesions before and daily during therapy. Wash area w/ soap & water, dry thoroughly. Apply 1/2 ointm from sgl use tube to ea nostril BID for 5 days. After app, close nostrils by pressing together & rel sides of nose repeatedly for 1 min. |
|
|
polyethylene glycol (MiraLax)
Class: Therapeutic-laxitives, Pharmacologic-osmotics Dosage:17 g (heaping T) in 8 oz of water; may be used for up to 2 wk. Route: PO MOA:Acts as an osmotic agent, drawing water into the lumen of the GI tract. Therapeutic: Evacuation of the GI tract w/o water or electrolyte imbalance. Onset: Unk Peak: 2-4 days Duration: Unk |
Major S/E: GI-Abd bloatinting, cramping, flatulence, nausea
Nursing: Assess pt for abd distention, presence of bowel sounds & usual pattern of bowel fx. Assess color, consistency & amt of stool produced. Dissolve powder in 8 oz water prior to administration. |
|
|
propranolol (Inderal)
Class: Therapeutic-antianginals, antiarrhythmics, antihypertensives, vascular h/a suppr. Pharmacologic: beta blockers Dosage: Mgt of tremor - 40 mg twice/day Route: PO MOA: blocks stim of beta-adrenergic rx sites. Therapeutic: Decr heart rate & bp. Suppression of arrhythmias. Prevention of MI. |
Onset: 30 min, Peak: 60-90 min.
Duration: 6-12 hr. Major S/E: CNS-fatigue, weakness, anx, dizzy, drowsy, insomnia, mem loss, depression EENT-blurred vision, dry eye, nasal stuffiness. RESP-bronchospasm, wheeze. CV- arrhythmias, bradycardia, chf, pulm edema, ortho hypo, periph vasoconstriction. GI-const, n/d. GU-impotence, decr libido. Derm-itch, rash. Endo-hyperglycemia, hypoglycemia. MS-arthralgia, back pain, muscle cramps. Neuro-parasthesia. Misc.-drug ind. lupus synd. Nursing:Monitor I&Os & daily wts. Assess for fluid overload (periph edema, dyspnea, rales, fatigue, wt gain, jvd.) |
|
|
ferrous gluconate
Class: Therapeutic-antianemics Pharmacologic-iron supplements Dosage:Adults (deficiency) 120-240 mg/day (2-3 mg/kg/day)in 2-4 divided doses (prophylaxis) 60-100 mg/day MOA: An essential mineral found in Hg, myoglobin & many enzymes. Perenteral irion enters bloodstream & organs of reticuloendothelial system(liver, spleen, bone marrow) where iron is separated out & becomes part of iron stores. Therapeutic: prev/trtment of iron deficiency. |
Onset: 4 days
Peak: 7-10 days Duration: 2-4 mos. Major S/E: GI-nausea, constipation, dark stools, diarrhea, epigastric pain. Nursing: Assess nutritional status & diet hx to det poss cause of anemia & need for pt teaching. Assess bowel fx for constipation or diarrhea. Notify physician if occurs Assess for s/s of anaphylaxis (rash, pruritus, laryngeal edema, wheezing). Notify ph Route: PO MOA:Promotes incorp of water into stool, resulting in softer fecal mass. May also promote electrolyte & water secretion into colon. Therapeutic Effect: softening & ys immediately if occur. Keep epi & resusc. equip close by. |
|
|
cyclobenzaprine (Flexeril)
Class: Therapeutic-skeletal muscle relaxants (centrally acting) Dosage: 10 mg TID (20-40 mg/day in 2-4 div doses; not to exceed 60 mg/day) Route: PO MOA: Reduces tonic somatic muscle activity at the level of the brainstem. Struct sim to tricyclic antidepressants. Therapeutic: Red in muscle spasm & hyperactivity w/o loss of fx. Onset: w/in 1 hr. Peak: 3-8 hr Duration: 12-24 hr. |
Major S/E: CNS-dizzy, drowsy, confusion, fatigue, h/a, nervous. EENT-dry mouth, blurred vision. CV-arrhythmias. GI-constipation, dyspepsia, nausea, unpleas.taste. GU-urinary retention.
Nursing: Assess for pain, muscle stiffness, & rom before & throughout therapy. Assess geri pts for sedation & weakness. |
|
|
enoxaparin (Lovenox)
Low Molecular Weight Heparin Class: Therapeutic-anticoaglant Pharmacologic-antithrombotic Dosage: 40 mg/day Route: Subcutaneous MOA: Potentiates the inhibitory effect of antithrombin on factor Xa and thrombin. Therapeutic: Prevention of thrombus formation. Onset: Unk Peak: Unk Duration: 12 hr. |
Major S/E:CNS-dizziness, h/a, insomnia. CV-edema. GI-constipation, nausea, reversible incr in liver enzymes, vomiting. GU-urniary retention. Derm-ecchymoses, pruritus, rash, urticaria. Hemat-bleeding, anemia, thrombocytopenia. Local- erythema @ inj site, hematoma, irritation, pain. Misc-fever.
Nursing:Assess for signs of bleeding & hemorrhage; bleeding from surg site. Notify phys if occurs. Assess for evid of addtl or incr thrombosis. Monitor neuro freq for impriarment. Monitor for hypersens rxns Do not expel air bubble from syringe before injection. Inject into L or R antero or posterolateral abd wall only |
|
|
insulin-rapid acting (Novolog)
Class: Therapeutic-antidiabetics, hormones Pharmacologic-pancreatics Dosage: Depends on blood glucose, response & other factors. Adults 0.5-1 unit/kg/day. Route: Subcutaneous MOA: Lower blood glucose by stimulating glucose uptake in skeletal muscle & fat, inhibiting hepatic glucose prod. Therapeutic: Control of blood glucose in diabetic pts. |
Onset: 15 min Peak: 1-3 hr
Duration: 3-5 hr Major S/E: Derm-urticaria. Endo-hypoglycemia, rebound hyperglycemia. Local-lipodystrophy, itching, swelling redness. Mis-allergic rxns, incl anaphylaxis. Nursing: Assess pt for s/s of hypoglycemia (anxiety, restless, mood chg, tingling in hands feet, lips, tongue, chills, cold sweats, confusion, cool, pale skin, diff conc, drowsy, exc hunger, h/a, nausea, rapid pulse, shaky) & hyperglycemia (confusion, drowsy, flushed, dry skin, fruity breath, rapid deep breathing, freq urination. |
|
|
mupirocin (Bactroban Nasal)
Class: Therapeutic-anti-infective Dosage: Apply 3-5 times/day for 5-14 days Route: Topical MOA: Inhibits bacterial protein synthesis Therapeutic: Inhibition of bact growth & reproduction. Onset: Unk Peak: Unk Duration: 12 hr. |
Major S/E: CNS-h/a. EENT-cough, itching, pharyngitis, rhinitis, upper resp tract congestion. GI-nausea, altered taste. Derm-burning, itching, pain, stinging.
Nursing: Assess lesions before and daily during therapy. Wash area w/ soap & water, dry thoroughly. Apply 1/2 ointm from sgl use tube to ea nostril BID for 5 days. After app, close nostrils by pressing together & rel sides of nose repeatedly for 1 min. |
|
|
propranolol (Inderal)
Class: Therapeutic-antianginals, antiarrhythmics, antihypertensives, vascular h/a suppr. Pharmacologic: beta blockers Dosage: Mgt of tremor - 40 mg twice/day Route: PO MOA: blocks stim of beta-adrenergic rx sites. Therapeutic: Decr heart rate & bp. Suppression of arrhythmias. Prevention of MI. |
Onset: 30 min, Peak: 60-90 min.
Duration: 6-12 hr. Major S/E: CNS-fatigue, weakness, anx, dizzy, drowsy, insomnia, mem loss, depression EENT-blurred vision, dry eye, nasal stuffiness. RESP-bronchospasm, wheeze. CV- arrhythmias, bradycardia, chf, pulm edema, ortho hypo, periph vasoconstriction. GI-const, n/d. GU-impotence, decr libido. Derm-itch, rash. Endo-hyperglycemia, hypoglycemia. MS-arthralgia, back pain, muscle cramps. Neuro-parasthesia. Misc.-drug ind. lupus synd. Nursing:Monitor I&Os & daily wts. Assess for fluid overload (periph edema, dyspnea, rales, fatigue, wt gain, jvd.) |
|
|
cyclobenzaprine (Flexeril)
Class: Therapeutic-skeletal muscle relaxants (centrally acting) Dosage: 10 mg TID (20-40 mg/day in 2-4 div doses; not to exceed 60 mg/day) Route: PO MOA: Reduces tonic somatic muscle activity at the level of the brainstem. Struct sim to tricyclic antidepressants. Therapeutic: Red in muscle spasm & hyperactivity w/o loss of fx. Onset: w/in 1 hr. Peak: 3-8 hr Duration: 12-24 hr. |
Major S/E: CNS-dizzy, drowsy, confusion, fatigue, h/a, nervous. EENT-dry mouth, blurred vision. CV-arrhythmias. GI-constipation, dyspepsia, nausea, unpleas.taste. GU-urinary retention.
Nursing: Assess for pain, muscle stiffness, & rom before & throughout therapy. Assess geri pts for sedation & weakness. |
